As of 2024-07-27, the Relative Valuation of Dicerna Pharmaceuticals Inc (DRNA) is (50.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 38.22 USD, the upside of Dicerna Pharmaceuticals Inc based on Relative Valuation is -233.0%.
The range of the Relative Valuation is (51.58) - (50.17) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 31.4x - 38.2x | 31.8x |
| Forward P/E multiples | 27.6x - 30.5x | 30.1x |
| Fair Price | (51.58) - (50.17) | (50.84) |
| Upside | -235.0% - -231.3% | -233.0% |
| Date | P/E |